[
    [
        {
            "time": "",
            "original_text": "智飞生物(300122)：新冠疫苗关键临床数据良好 临床III期将继续开展",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "临床数据",
                    "临床III期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物(300122)：新冠疫苗关键临床数据良好 临床III期将继续开展",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "中原证券：10月金股组合跌0.48% 11月荐股名单出炉",
            "features": {
                "keywords": [
                    "中原证券",
                    "金股组合",
                    "荐股名单"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "中原证券：10月金股组合跌0.48% 11月荐股名单出炉",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "强劲增长 56家重庆A股前三季赚277亿元 谁是业绩王？",
            "features": {
                "keywords": [
                    "重庆A股",
                    "业绩",
                    "强劲增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "强劲增长 56家重庆A股前三季赚277亿元 谁是业绩王？",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "无症状感染者猛增！全球新冠疫苗最新进展盘点",
            "features": {
                "keywords": [
                    "无症状感染者",
                    "新冠疫苗",
                    "进展"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "无症状感染者猛增！全球新冠疫苗最新进展盘点",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "219只个股业绩超预期，五十强集中于电子、化工、医药生物等行业",
            "features": {
                "keywords": [
                    "个股",
                    "业绩超预期",
                    "电子",
                    "化工",
                    "医药生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "电子",
                    "化工",
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "219只个股业绩超预期，五十强集中于电子、化工、医药生物等行业",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "东北证券：后疫情时代医药行业投资机遇 2021年继续看好疫苗、创新药等领域",
            "features": {
                "keywords": [
                    "东北证券",
                    "后疫情时代",
                    "医药行业",
                    "疫苗",
                    "创新药"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "东北证券：后疫情时代医药行业投资机遇 2021年继续看好疫苗、创新药等领域",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[中原策略]2020年第十一期：11月1日-11月30日：中原证券2020年11月十大金股组合",
            "features": {
                "keywords": [
                    "中原证券",
                    "金股组合",
                    "11月"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[中原策略]2020年第十一期：11月1日-11月30日：中原证券2020年11月十大金股组合",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物重组新冠疫苗二期数据优异 三期临床即将在乌兹别克斯坦启动",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "二期数据",
                    "三期临床"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物重组新冠疫苗二期数据优异 三期临床即将在乌兹别克斯坦启动",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "最新金股名单来了！上月最牛金股大涨85%",
            "features": {
                "keywords": [
                    "金股名单",
                    "大涨"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最新金股名单来了！上月最牛金股大涨85%",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[东北医药崔洁铭/樊翔宇】医药行业2021年投资策略：后疫情时代医药行业投资机遇",
            "features": {
                "keywords": [
                    "东北医药",
                    "后疫情时代",
                    "医药行业",
                    "投资策略"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[东北医药崔洁铭/樊翔宇】医药行业2021年投资策略：后疫情时代医药行业投资机遇",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫情影响逐渐消退，关注高成长龙头+细分冠军 -- 医药生物上市公司2020年三季报小结",
            "features": {
                "keywords": [
                    "疫情影响",
                    "高成长龙头",
                    "细分冠军",
                    "医药生物",
                    "三季报"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫情影响逐渐消退，关注高成长龙头+细分冠军 -- 医药生物上市公司2020年三季报小结",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
            "features": {
                "keywords": [
                    "浙商医药",
                    "三季报",
                    "创新药",
                    "CDMO"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[浙商医药|三季报】创新药研发高景气有望持续，看好CDMO业绩加速",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]